Background: In Togo, the HIV/AIDS epidemic is characterized by the circulation
of the 2 subtypes of HIV. Thus, patients infected with HIV-2 are diagnosed
and monitored in the care centers. Objective: To document the trend
of HIV-2 prevalence over a decade of activities of the National Reference
Center for HIV tests and screening (CNR-VIH). Methods: A cross sectional
study was carried out from the screening data archived from January 2005 to
December 2014 at the CNR-VIH, a laboratory located in the Sylvanus Olympio
University Hospital (CHU SO) Lome. The sampling consisted of adults
and children outpatients or those who were hospitalized in CHU SO, subjects
presenting for voluntary testing, pregnant women and patients or samples referred
for HIV confirmation. All samples were tested for HIV-1 and HIV-2
infections by combining ELISA and rapid diagnostic tests. Result: During the
decade, 34,077 subjects were screened for HIV infection. The overall prevalence
of HIV infection was 20.70% (7055/34077). In 10 years, the prevalence
of HIV infection in CNR-VIH decreased significantly from 35.40% CI95% [34.50% - 36.20%] in 2005 to 14.20% CI95% [13.60% - 14.70%] in 2014 (p =
0.03). The prevalence of HIV-1, HIV-2 and dual HIV1&HIV-2 was respectively
20.40%, 0.23% and 0.07%, with annual prevalence of HIV-2 between
0.07% and 0.39%. The differences between the HIV-2 prevalence over the
decade were not statistically significant (p > 0.15). A 4-year-old child from
mother-to-child HIV-2 transmission was diagnosed. Sixty-five percent of
adult patients were over 40 years of age with an average age of 43.5 ± 11.3
years. Conclusion: Data from the National Reference Center for HIV Tests in Togo over the last ten years confirm the existence of a weak epidemic of HIV-
2 infection with a tendency towards stability.
References
[1]
Bock, J.P. and Markovitz, M.D. (2001) Infection with HIV-2. AIDS, 15, S35-S45.
https://doi.org/10.1097/00002030-200100005-00006
[2]
Visseaux, B., Damond, F., Matheron, S., Deschamps, D. and Charpentier, C. (2016) HIV-2 Molecular Epidemiology. Infection Genetics and Evolution, 46, 233-240.
https://doi.org/10.1016/j.meegid.2016.08.010
[3]
Damond, F., Apetrei, C., Robertson, D.L., Souquière, S., Leprêtre, A., Matheron, S., et al. (2001) Variability of Human Immunodeficiency Virus Type 2 (HIV-2) Infecting Patients Living in France. Virology, 280, 19-30.
https://doi.org/10.1006/viro.2000.0685
[4]
Torian, L.V., Eaveyy, J.J., Punsalang, A.P., Pirillo, R.E., Forgione, L.A., Kent, S.A. and Oleszko, W.R. (2010) HIV Type 2 in New York City, 2000-2008. Clinical Infectious Diseases, 51, 1334-1342. https://doi.org/10.1086/657117
[5]
Valadas, E., Franca, L., Sousa, S. and Antunes, F. (2009) 20 Years of HIV-2 Infection in Portugal: Trends and Changes in Epidemiology. Clinical Infectious Diseases, 48, 1166-1167. https://doi.org/10.1086/597504
[6]
De Silva, T.I., Cotton, M. and Rowland-Jones, S.L. (2008) HIV-2: The Forgotten AIDS Virus. Trends in Microbiology, 16, 588-595.
https://doi.org/10.1016/j.tim.2008.09.003
[7]
Popper, S.J., Sarr, A.D., Travers, K.U., Guèye-Ndiaye, A., Mboup, S., et al. (1999) Lower Immunodeficiency Virus (HIV) Type 2 Viral Load Reflets the Difference in Pathogenicity of HIV-1 and HIV-2. The Journal of Infectious Diseases, 180, 1116-1121. https://doi.org/10.1086/315010
[8]
Jaffar, S., Grant, A.D., Whitworth, J., Smith, P.G. and Whittle, H. (2004) The Natural History of HIV-1 and HIV-2 Infections in Adults in Africa: A Literature Review. Bulletin WHO, 82, 462-469.
[9]
Prince, P.D., Master, A., van Tienen, C., Whittle, H.C., Schim and van de Loeff, M.F. (2014) Mortality Rates in People Dually Infected with HIV-1/2 and Those Infected with Either HIV-1 or HIV-2: A Systematic Review and Meta-Analysis. AIDS 2014, 28, 549-558.
[10]
Witvrouw, M., Pannecouque, C., Switzer, W.M., Folks, T.M., De Clercq, E. and Heneine, W. (2004) Susceptibility of HIV-2, SIV and SHIV to Various Anti-HIV-1 Compounds: Implications for Treatment and Postexposure Prophylaxis. Antiviral Therapy, 9, 57-65.
[11]
Peterson, K., Jallow, S., Rowland-Jones, S. and de Silva, T.I. (2011) Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings. AIDS Research and Treatment, 2011, Article ID: 463704.
https://doi.org/10.1155/2011/463704
[12]
Eholie, S. and Anglaret, X. (2006) Commentary: Decline of HIV-2 Prevalence in West Africa: Good News or Bad News? International Journal of Epidemiology, 35, 1329-1330. https://doi.org/10.1093/ije/dyl156
[13]
Da Silva, Z.J., Oliveira, I., Andersen, A., Dias, F., Rodrigues, A., Holmgren, B., Andersson, S. and Aaby, P. (2008) Changes in Prevalence and Incidence of HIV-1, HIV-2 and Dual Infections in Urban Areas of Bissau, Guinea-Bissau: Is HIV-2 Disappearing? AIDS, 22, 1195-1202. https://doi.org/10.1097/QAD.0b013e328300a33d
[14]
Tienen, C., van der Loeff, M.S., Zaman, S.M.A., Vincent, T., Sarge-Njie, R., Peterson, I., et al. (2010) Two Distinct Epidemics: The Rise of HIV-1 and Decline of HIV-2 Infection between 1990 and 2007 in Rural Guinea-Bissau. JAIDS Journal of Acquired Immune Deficiency Syndromes, 53, 640-647.
[15]
Ministère de la planification du développement et de l’aménagement du territoire (MPDAT) Ministère de la santé (MS) et ICF International (2015) Togo: Enquête démographique et de Santé 2013-2014. Rockville.
[16]
PNLS (2007) Politique, normes et directives nationales de conseil et dépistage volontaire en matière d’infection par le VIH au Togo.
[17]
Sanou, M., Soubeiga, S.T., Bationo, F., Compaore, T.R., Zohoncon, T.M., Diatto, G.N., et al. (2014) A Decade of Follow-Up and Therapeutic Drug Monitoring in HIV-2 Immunocompromised Patients at St Camille and General Lamizana Military Medical Centers, Burkina Faso, West Africa. Pakistan Journal of Biological Sciences, 17, 1219-1224. https://doi.org/10.3923/pjbs.2014.1219.1224
[18]
Odaibo, G.N. and Olaleye, D.O. (2013) Laboratory Profile of HIV-2 and Dual HIV-1/HIV-2 Associated Acquired Immunodeficiency Syndrome in Nigeria. World Journal of AIDS, 3, 192-196. https://doi.org/10.4236/wja.2013.33025
[19]
Van Der Loeff, M.F.S., Awasana, A.A., Sarge-Njie, Van Der Sande, M., Jaye, A., et al. (2006) Sixteen Years of HIV Surveillance in a West African Research Clinic Reveals Divergent Epidemic Trends of HIV-1 and HIV-2. International Journal of Epidemiology, 35, 1322-1328. https://doi.org/10.1093/ije/dyl037
[20]
Burgard, M., Jasseron, C., Matheron, S., Damond, F., Hamrene, K., et al. (2010) Mother-to-Child Transmission of HIV-2 Infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1. Clinical Infectious Diseases, 51, 833-843.
https://doi.org/10.1086/656284
[21]
Adjorlolo-Johnson, G., De Cock, K.M., Ekpini, E., Vetter, K.M., Sibailly, T., Brattegaard, K., et al. (1994) Prospective Comparison of Mother-to-Child Transmission of HIV-1 and HIV-2 in Abijan, Ivory Coast. JAMA, 272, 462-466.
https://doi.org/10.1001/jama.1994.03520060062033
[22]
O’Donovan, D., Ariyoshi, K., Milligan, P., Ota, M., Yamuah, L., et al. (2000) Maternal Plasma Viral RNA Levels Determine Marked Differences in Mother-to-Child Transmission Rates of HIV-1 and HIV-2 in the Gambia. AIDS, 14, 441-448.
https://doi.org/10.1097/00002030-200003100-00019
[23]
Fryer, H.R., Van Tienen, C., Van Der Loeff, M.S., Aaby, P., Da Silva, Z.J., et al. (2015) Predicting the Extinction of HIV-2 in Rural Guinea-Bissau. AIDS, 29, 2479-2486. https://doi.org/10.1097/QAD.0000000000000844
[24]
Tchounga, B., Inwoley, A., Coffie, P., Minta, D., Messou, E., et al. (2014) Re-Testing and Misclassification of HIV-2 and HIV-1&2 Dually Reactive Patients among the HIV-2 Cohort of the West African Database to Evaluate AIDS Collaboration. Journal of the International AIDS Society, 17, 19064.
https://doi.org/10.7448/IAS.17.1.19064
